Enjaymo (sutimlimab-jome) eased anemia, and reduced fatigue and the need for blood transfusions and other treatments in people with…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Either a hot water bath or a blood warmer attached to an infusion pump may be used to warm up…
The case of a man with cold agglutinin disease (CAD) that was found to be secondary to a blood…
The case of a man with cold agglutinin disease (CAD) co-occurring with a blood cell disorder called myelodysplastic syndrome…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…
Mortality rates are generally higher among people with cold agglutinin disease (CAD) and related conditions than in the general…
A case of cold agglutinin disease (CAD) secondary to bacterial infection in a young woman in the U.K. was…
COVID-19 can worsen symptoms of cold agglutinin disease (CAD), a recent case report highlights. The scientists stressed the need…
The U.S. Food and Drug Administration (FDA) has approved Enjaymo (sutimlimab-jome) to decrease the need for red blood cell…
A bone marrow biopsy may be useful as a test for an underlying cancer or other conditions involving the excessive…